A股異動丨永安行一度跌停 上海聯適65%股份交易“吿吹”
永安行(603776.SH)開盤一度跌停,現報14.11元跌幅收窄至8.6%,總市值33.8億元。消息上,永安行上週五盤後公吿,終止買聯適導航65%股份,估值等條款未達成一致。公開資料顯示,上海聯適主營業務為農機自動駕駛系統(佔營收超70%)及智慧農業解決方案,曾於2023年6月申請科創板IPO,但2024年7月因撤回申請終止上市 。其2022-2023年營收分別為3.15億元、4.22億元,淨利潤5287萬元、6327萬元 。IPO失敗後,上海聯適面臨行業價格戰及競爭加劇問題,急需融資渠道。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.